Clinical Trials Directory

Trials / Conditions / Stage III Lung Non-Small Cell Cancer AJCC v7

Stage III Lung Non-Small Cell Cancer AJCC v7

10 registered clinical trials studyying Stage III Lung Non-Small Cell Cancer AJCC v7 — 1 currently recruiting.

StatusTrialSponsorPhase
RecruitingLocal Consolidative Therapy and Durvalumab for Oligoprogressive and Polyprogressive Stage III NSCLC After Chem
NCT04892953
M.D. Anderson Cancer CenterPhase 2
Active Not RecruitingTesting the Combination of MLN0128 (TAK-228) and AZD9291 in Advanced EGFR (Epidermal Growth Factor Receptor) M
NCT02503722
National Cancer Institute (NCI)Phase 1
Active Not RecruitingA Phase 2 Study of Cediranib in Combination With Olaparib in Advanced Solid Tumors
NCT02498613
National Cancer Institute (NCI)Phase 2
CompletedOsimertinib and Navitoclax in Treating Patients With EGFR-Positive Previously Treated Advanced or Metastatic N
NCT02520778
National Cancer Institute (NCI)Phase 1
TerminatedGenetically Modified T-Cell Therapy in Treating Patients With Advanced ROR1+ Malignancies
NCT02706392
Fred Hutchinson Cancer CenterPhase 1
CompletedMethoxyamine Hydrochloride, Pemetrexed Disodium, Cisplatin, and Radiation Therapy in Treating Patients With St
NCT02535325
National Cancer Institute (NCI)Phase 1
TerminatedNintedanib Compared With Placebo in Treating Against Radiation-Induced Pneumonitis in Patients With Non-small
NCT02452463
Roswell Park Cancer InstitutePhase 2
TerminatedTrametinib, Combination Chemotherapy, and Radiation Therapy in Treating Patients With Stage III Non-small Cell
NCT01912625
National Cancer Institute (NCI)Phase 1
UnknownStudy of Positron Emission Tomography and Computed Tomography in Guiding Radiation Therapy in Patients With St
NCT01507428
National Cancer Institute (NCI)Phase 2
Active Not RecruitingVeliparib With or Without Radiation Therapy, Carboplatin, and Paclitaxel in Patients With Stage III Non-small
NCT01386385
National Cancer Institute (NCI)Phase 1 / Phase 2